Fulminant myocarditis in the time of coronavirus
- PMID: 32338735
- PMCID: PMC7197560
- DOI: 10.1093/eurheartj/ehaa354
Fulminant myocarditis in the time of coronavirus
Comment on
-
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190. Eur Heart J. 2021. PMID: 32176300 Free PMC article. No abstract available.
References
-
- Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–2648. - PubMed
-
- Tomioka N, Kishimoto C, Matsumori A, Kawai C.. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol 1986;7:868–872. - PubMed
